文献速递心力衰竭与心肌病

慢性心力衰竭管理与远程血流动力学监测

Chronic heart failure management and remote haemodynamic monitoring.
PubMed 文献 · Heart · 2018-08-18

本文综述了远程血流动力学监测在慢性心力衰竭管理中的应用。早期研究提示血流动力学淤血先于临床淤血数周,近期前瞻性单盲试验证实基于肺动脉压力指导的管理可减少未来心衰住院,后续商业使用研究支持其效用,事后分析提示其可能成为指南指导药物治疗和器械治疗之外的额外支柱。

要点

  • 远程血流动力学监测可减少心衰住院。
  • 血流动力学淤血先于临床淤血数周。
  • 该策略可能成为心衰治疗的额外支柱。

核心结论

  • 远程肺动脉压力指导的心衰管理可减少未来心衰住院,可能成为指南指导药物治疗和器械治疗之外的额外治疗支柱。

研究设计与样本

  • 综述性文章,总结了远程血流动力学监测在心力衰竭管理中的研究进展。

主要发现

  • 早期研究表明血流动力学淤血先于临床淤血数周,远程监测心内压力可能是可行且实用的管理策略。
  • 一项前瞻性单盲试验中,随机分配到主动压力指导心衰管理组减少了未来心衰住院。
  • 后续商业使用研究强化了该技术的效用,事后分析提示紧密血流动力学管理可能成为额外治疗支柱。

临床怎么用

  • 对于慢性心力衰竭患者,可考虑使用远程肺动脉压力监测指导管理以减少心衰住院。
  • 该策略可能作为指南指导药物治疗和器械治疗之外的补充。

局限性

  • 早期研究受设备完整性和植入相关不良事件困扰。
  • 需要正在进行的临床试验进一步明确该策略在不同心衰患者中的适用范围和效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heart failure (HF) has a large societal and economic burden and is expected to increase in magnitude and complexity over the ensuing years. A number of telemonitoring strategies exploring remote monitoring and management of clinical signs and symptoms of congestion in HF have had equivocal results. Early studies of remote haemodynamic monitoring showed promise, but issues with device integrity and implantation-associated adverse events hindered progress. Nonetheless, these early studies established that haemodynamic congestion precedes clinical congestion by several weeks and that remote monitoring of intracardiac pressures may be a viable and practical management strategy. Recently, the safety and efficacy of remote pulmonary artery pressure-guided HF management was established in a prospective, single-blind trial where randomisation to active pressure-guided HF management reduced future HF hospitalisations. Subsequent commercial use studies reinforced the utility of this technology and post hoc analyses suggest that tight haemodynamic management of patients with HF may be an additional pillar of therapy alongside established guideline-directed medical and device therapy. Currently, there is active exploration into utilisation of this technology and management paradigm for the timing of implantation of durable left ventricular assist devices (LVAD) and even optimisation of LVAD therapy. Several ongoing clinical trials will help clarify the extent and utility of this strategy along the spectrum of patient with HF from individuals with chronic, stable HF to those with more advanced disease requiring heart replacement therapy.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Wolfson AM, Fong M, Grazette L, et al. Chronic heart failure management and remote haemodynamic monitoring. Heart. 2018. PMID: 30121633. doi:10.1136/heartjnl-2018-313397

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。